A detailed history of Brown Brothers Harriman & CO transactions in Novo Nordisk A S stock. As of the latest transaction made, Brown Brothers Harriman & CO holds 37,367 shares of NVO stock, worth $3.22 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
37,367
Previous 35,679 4.73%
Holding current value
$3.22 Million
Previous $5.09 Million 12.63%
% of portfolio
0.03%
Previous 0.04%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$119.07 - $145.42 $200,990 - $245,468
1,688 Added 4.73%
37,367 $4.45 Million
Q2 2024

Aug 09, 2024

BUY
$122.71 - $146.91 $1.5 Million - $1.8 Million
12,257 Added 52.33%
35,679 $5.09 Million
Q1 2024

May 10, 2024

BUY
$102.11 - $135.92 $213,001 - $283,529
2,086 Added 9.78%
23,422 $3.01 Million
Q4 2023

Feb 12, 2024

SELL
$87.78 - $105.45 $85,848 - $103,130
-978 Reduced 4.38%
21,336 $2.21 Million
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $1.17 Million - $2.57 Million
12,886 Added 136.68%
22,314 $2.03 Million
Q2 2023

Aug 07, 2023

SELL
$155.98 - $172.65 $49,913 - $55,248
-320 Reduced 3.28%
9,428 $1.53 Million
Q1 2023

May 11, 2023

SELL
$132.34 - $159.14 $1,985 - $2,387
-15 Reduced 0.15%
9,748 $1.55 Million
Q4 2022

Feb 09, 2023

BUY
$102.55 - $135.33 $2,358 - $3,112
23 Added 0.24%
9,763 $1.32 Million
Q3 2022

Nov 10, 2022

BUY
$95.28 - $116.93 $13,720 - $16,837
144 Added 1.5%
9,740 $970,000
Q2 2022

Aug 11, 2022

BUY
$103.24 - $121.81 $6,194 - $7,308
60 Added 0.63%
9,596 $1.07 Million
Q1 2022

May 13, 2022

BUY
$93.1 - $112.54 $367,558 - $444,307
3,948 Added 70.65%
9,536 $1.06 Million
Q3 2021

Nov 15, 2021

SELL
$84.42 - $106.62 $1,181 - $1,492
-14 Reduced 0.25%
5,588 $537,000
Q1 2021

May 13, 2021

SELL
$67.06 - $75.82 $307,872 - $348,089
-4,591 Reduced 45.04%
5,602 $378,000
Q4 2020

Feb 16, 2021

BUY
$63.89 - $73.8 $62,037 - $71,659
971 Added 10.53%
10,193 $712,000
Q3 2020

Nov 16, 2020

SELL
$63.69 - $70.22 $51,206 - $56,456
-804 Reduced 8.02%
9,222 $640,000
Q2 2020

Aug 13, 2020

BUY
$58.54 - $67.94 $311,081 - $361,033
5,314 Added 112.78%
10,026 $657,000
Q1 2020

May 15, 2020

SELL
$49.46 - $64.78 $143,829 - $188,380
-2,908 Reduced 38.16%
4,712 $284,000
Q4 2019

Feb 14, 2020

SELL
$49.86 - $58.26 $76,435 - $89,312
-1,533 Reduced 16.75%
7,620 $441,000
Q3 2019

Nov 14, 2019

BUY
$47.54 - $53.43 $64,987 - $73,038
1,367 Added 17.56%
9,153 $473,000
Q2 2019

Aug 14, 2019

BUY
$46.79 - $52.47 $13,381 - $15,006
286 Added 3.81%
7,786 $397,000
Q1 2019

May 15, 2019

BUY
$46.36 - $52.63 $75,103 - $85,260
1,620 Added 27.55%
7,500 $392,000
Q4 2018

Feb 14, 2019

BUY
$41.54 - $47.25 $15,785 - $17,955
380 Added 6.91%
5,880 $271,000
Q3 2018

Nov 14, 2018

BUY
$46.76 - $51.24 $121,576 - $133,224
2,600 Added 89.66%
5,500 $259,000
Q1 2018

May 14, 2018

SELL
$48.49 - $58.14 $379,773 - $455,352
-7,832 Reduced 72.98%
2,900 $143,000
Q4 2017

Feb 14, 2018

BUY
$47.53 - $53.73 $372,254 - $420,813
7,832 Added 270.07%
10,732 $576,000
Q2 2017

Aug 14, 2017

BUY
N/A
2,900
2,900 $124,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $195B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Brown Brothers Harriman & CO Portfolio

Follow Brown Brothers Harriman & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Brothers Harriman & CO, based on Form 13F filings with the SEC.

News

Stay updated on Brown Brothers Harriman & CO with notifications on news.